FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...

FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...

FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...

Today we officially welcomed two new Illumina Novaseq XPlus sequencers with a company-wide ribbon cutting ceremony. We can’t wait to complete validation (already under way!)…

Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...

Valued Customers, We would like to update you on our winter holiday hours of operation:  Our offices will be closed...

STUTTGART, Germany, Nov. 15, 2021  PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...

Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...

March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...

January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...